Target intelligence / Profile preview

ANKRD44 divergent transcript (ANKRD44-DT)

Target: ANKRD44-DT
Molecular classification: Long non-coding RNA (lncRNA), Divergent transcript

Overview

ANKRD44 divergent transcript (ANKRD44-DT) is a long non-coding RNA (lncRNA) gene located in proximity to the protein-coding gene ANKRD44. It is classified as a divergent transcript because it is transcribed in the opposite direction from a promoter region shared with an adjacent protein-coding gene[5][6]. At present, there is no experimentally demonstrated function, disease relevance, or role as a therapeutic target for ANKRD44-DT[5]. There are no reported drug interactions, biomarker uses, or safety considerations associated with this gene.

Mechanism of action

None applicable (no known drug mechanism related to this molecule)

Biological functions

Unknown/Other (currently, there is no characterized biological function reported for this specific lncRNA)

Disease associations

None documented (no established link between ANKRD44-DT and disease in current references)

Safety considerations

None known (no therapeutic or diagnostic usage, hence no reported safety issues)

Interacting drugs

None known (no drugs are known to target or interact with this lncRNA)

Biomarkers

None established (not currently used as a biomarker)

Beyond the preview

Go deeper on ANKRD44 divergent transcript (ANKRD44-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD44 divergent transcript (ANKRD44-DT).

Explore the full profile